Forian Inc. Reports Significant Growth in Second Quarter 2025 Financial Results

Forian Inc., a leader in data science-driven information and analytics solutions for the life science, healthcare, and financial services sectors, has announced its financial results for the second quarter of 2025. The company reported a significant 56% increase in revenue, reaching $7.5 million, up from $4.8 million in the same period last year. This growth is attributed to strategic contract renewals, new client acquisitions, and operational efficiencies.

The net income for the quarter stood at $0.2 million, or $0.01 per share, a substantial improvement from a net loss of $2.6 million, or $0.08 per share, in the second quarter of 2024. Adjusted EBITDA also saw a dramatic increase to $0.6 million, compared to $0.1 million in the prior year, highlighting the company's enhanced profitability and margin expansion.

Max Wygod, CEO and Executive Chairman of Forian, emphasized the company's focus on both organic growth and strategic investments to strengthen its platform and deliver value across the healthcare ecosystem. The company's cash, cash equivalents, and marketable securities totaled $35.6 million as of June 30, 2025, providing a solid foundation for future growth and investment.

Forian has also reconfirmed its full-year 2025 outlook, expecting revenue to be between $28 to $30 million and Adjusted EBITDA to range from ($1.0) to $1.0 million. This optimistic forecast is based on the company's current estimates and reflects confidence in its continued growth trajectory.

For more detailed financial information and to access the webcast discussing these results, interested parties can visit https://www.forian.com/investors. The company's performance in the second quarter of 2025 underscores its ability to execute its business strategy effectively, driving revenue growth and operational discipline in a competitive market.